73.44BMarket Cap16.72P/E (TTM)
184.71High178.00Low11.67KlotVolume184.00Open184.99Pre Close211.11MTurnover1.29%Turnover RatioLossP/E (Static)401.00MShares188.0052wk High14.24P/B16.56BFloat Cap71.0152wk Low221.99Limit Up90.45MShs Float188.00Historical High147.99Limit Down3.63%Amplitude28.75Historical Low--Dividend TTM180.83Avg Price6.67KlotAsk--Div YieldTTM100Lot Size4.78KlotBid
Sichuan Biokin Pharmaceutical Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
No comment yet